{"id":21,"date":"2025-07-15T15:51:05","date_gmt":"2025-07-15T15:51:05","guid":{"rendered":"https:\/\/paladin-pharma-dev.fdandre.app.br\/paladin\/?page_id=21"},"modified":"2025-09-12T17:34:16","modified_gmt":"2025-09-12T17:34:16","slug":"home","status":"publish","type":"page","link":"https:\/\/paladin-pharma.com\/","title":{"rendered":"Home"},"content":{"rendered":"\t\t<div data-elementor-type=\"wp-page\" data-elementor-id=\"21\" class=\"elementor elementor-21\">\n\t\t\t\t\t\t<section class=\"elementor-section elementor-top-section elementor-element elementor-element-18f20bd9 elementor-section-height-min-height elementor-section-items-top elementor-section-content-top elementor-section-boxed elementor-section-height-default\" data-id=\"18f20bd9\" data-element_type=\"section\" data-settings=\"{&quot;background_background&quot;:&quot;classic&quot;}\">\n\t\t\t\t\t\t<div class=\"elementor-container elementor-column-gap-no\">\n\t\t\t\t\t<div class=\"elementor-column elementor-col-100 elementor-top-column elementor-element elementor-element-40f1a703\" data-id=\"40f1a703\" data-element_type=\"column\" data-settings=\"{&quot;background_background&quot;:&quot;classic&quot;}\">\n\t\t\t<div class=\"elementor-widget-wrap elementor-element-populated\">\n\t\t\t\t\t\t<div class=\"elementor-element elementor-element-7b047093 elementor-invisible elementor-widget elementor-widget-image\" data-id=\"7b047093\" data-element_type=\"widget\" data-settings=\"{&quot;_animation&quot;:&quot;fadeInRight&quot;}\" data-widget_type=\"image.default\">\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<img decoding=\"async\" src=\"https:\/\/paladin-pharma.com\/wp-content\/uploads\/elementor\/thumbs\/slider_15-2-r8t0d14i5rckafz05kwe1bju11t7augbjorgab8bnk.jpg\" title=\"slider_15-2\" alt=\"slider_15-2\" loading=\"lazy\" \/>\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t<section class=\"elementor-section elementor-top-section elementor-element elementor-element-24568cf4 elementor-section-boxed elementor-section-height-default elementor-section-height-default\" data-id=\"24568cf4\" data-element_type=\"section\" data-settings=\"{&quot;background_background&quot;:&quot;classic&quot;}\">\n\t\t\t\t\t\t<div class=\"elementor-container elementor-column-gap-default\">\n\t\t\t\t\t<div class=\"elementor-column elementor-col-100 elementor-top-column elementor-element elementor-element-40d6d65b\" data-id=\"40d6d65b\" data-element_type=\"column\">\n\t\t\t<div class=\"elementor-widget-wrap elementor-element-populated\">\n\t\t\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t<section class=\"elementor-section elementor-top-section elementor-element elementor-element-361b66d2 elementor-section-boxed elementor-section-height-default elementor-section-height-default\" data-id=\"361b66d2\" data-element_type=\"section\" data-settings=\"{&quot;background_background&quot;:&quot;classic&quot;}\">\n\t\t\t\t\t\t<div class=\"elementor-container elementor-column-gap-default\">\n\t\t\t\t\t<div class=\"elementor-column elementor-col-100 elementor-top-column elementor-element elementor-element-9712867\" data-id=\"9712867\" data-element_type=\"column\">\n\t\t\t<div class=\"elementor-widget-wrap elementor-element-populated\">\n\t\t\t\t\t\t<div class=\"elementor-element elementor-element-7fe44cc3 elementor-widget elementor-widget-heading\" data-id=\"7fe44cc3\" data-element_type=\"widget\" data-widget_type=\"heading.default\">\n\t\t\t\t\t<h1 class=\"elementor-heading-title elementor-size-default\">A leader in specialty pharmaceutical innovation.<\/h1>\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-77085328 elementor-widget elementor-widget-heading\" data-id=\"77085328\" data-element_type=\"widget\" data-widget_type=\"heading.default\">\n\t\t\t\t\t<span class=\"elementor-heading-title elementor-size-default\">Welcome to Paladin Pharma Inc.<\/span>\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-b27c0f3 elementor-widget__width-initial elementor-widget elementor-widget-text-editor\" data-id=\"b27c0f3\" data-element_type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t\t\t\t\t\t<p><a href=\"https:\/\/investors.knighttx.com\/English\/news\/news-details\/2025\/Knight-Therapeutics-Announces-Closing-of-Previously-Announced-Acquisition-of-Paladin\/default.aspx\" target=\"_blank\" rel=\"noopener\"><strong>Knight Therapeutics Announces Closing of Previously Announced Acquisition of Paladin<\/strong><\/a><br \/>06\/17\/2025<br \/>MONTREAL, June 17, 2025 (GLOBE NEWSWIRE) &#8212; Knight Therapeutics Inc. (TSX: GUD) (&#8220;Knight&#8221;), a pan-American (ex-US) specialty pharmaceutical company, announced today that it has completed the acquisition of the Paladin business, under the terms of the definitive Asset Purchase Agreement (\u201cAPA\u201d) entered with Paladin Pharma Inc., an Endo, Inc. operating company, as announced in March 2025.<\/p><p><a href=\"https:\/\/investors.knighttx.com\/English\/news\/news-details\/2025\/Knight-Therapeutics-Announces-Closing-of-Previously-Announced-Acquisition-of-Paladin\/default.aspx\" target=\"_blank\" rel=\"noopener\">Read more<\/a><\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t<section class=\"elementor-section elementor-top-section elementor-element elementor-element-3b65fa3a elementor-section-boxed elementor-section-height-default elementor-section-height-default\" data-id=\"3b65fa3a\" data-element_type=\"section\" data-settings=\"{&quot;background_background&quot;:&quot;classic&quot;}\">\n\t\t\t\t\t\t<div class=\"elementor-container elementor-column-gap-default\">\n\t\t\t\t\t<div class=\"elementor-column elementor-col-100 elementor-top-column elementor-element elementor-element-27cfd9d9\" data-id=\"27cfd9d9\" data-element_type=\"column\">\n\t\t\t<div class=\"elementor-widget-wrap elementor-element-populated\">\n\t\t\t\t\t\t<div class=\"elementor-element elementor-element-d31421c elementor-invisible elementor-widget elementor-widget-heading\" data-id=\"d31421c\" data-element_type=\"widget\" data-settings=\"{&quot;_animation&quot;:&quot;slideInLeft&quot;}\" data-widget_type=\"heading.default\">\n\t\t\t\t\t<h2 class=\"elementor-heading-title elementor-size-default\">An innovative specialty pharmaceutical company<\/h2>\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t<div class=\"elementor-element elementor-element-714ef4c e-flex e-con-boxed e-con e-parent\" data-id=\"714ef4c\" data-element_type=\"container\">\n\t\t\t\t\t<div class=\"e-con-inner\">\n\t\t\t\t<div class=\"elementor-element elementor-element-c6391e3 elementor-widget elementor-widget-heading\" data-id=\"c6391e3\" data-element_type=\"widget\" data-widget_type=\"heading.default\">\n\t\t\t\t\t<h2 class=\"elementor-heading-title elementor-size-default\">Press Releases<\/h2>\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t<div class=\"elementor-element elementor-element-ca3781d e-flex e-con-boxed e-con e-parent\" data-id=\"ca3781d\" data-element_type=\"container\">\n\t\t\t\t\t<div class=\"e-con-inner\">\n\t\t\t\t<div class=\"elementor-element elementor-element-27bb980 elementor-widget elementor-widget-text-editor\" data-id=\"27bb980\" data-element_type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t\t\t\t\t\t<p><strong>29-Jun-2023<br \/><\/strong><a href=\"https:\/\/www.paladin-pharma.com\/wp-content\/uploads\/2023\/06\/Xcopri%20Press%20Release_EN.pdf\" target=\"_blank\" rel=\"noopener\">Endo Announces Approval of XCOPRI\u2122 (cenobamate tablets) in\u00a0Canada<\/a><\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t<div class=\"elementor-element elementor-element-c553c61 e-flex e-con-boxed e-con e-parent\" data-id=\"c553c61\" data-element_type=\"container\">\n\t\t\t\t\t<div class=\"e-con-inner\">\n\t\t\t\t<div class=\"elementor-element elementor-element-2bc6d37 elementor-widget elementor-widget-text-editor\" data-id=\"2bc6d37\" data-element_type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t\t\t\t\t\t<p><strong>08-Aug-2022<\/strong><br \/><a href=\"https:\/\/www.paladin-pharma.com\/wp-content\/uploads\/2022\/08\/Cenobamate_Press%20Release_EN.pdf\" target=\"_blank\" rel=\"noopener\">Paladin Labs Announces Health Canada\u2019s Filing Acceptance of Cenobamate Tablets as an Adjunctive Therapy for the Management of Partial-Onset Seizures in Adults with Epilepsy<\/a><\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t<div class=\"elementor-element elementor-element-4323b8b e-flex e-con-boxed e-con e-parent\" data-id=\"4323b8b\" data-element_type=\"container\">\n\t\t\t\t\t<div class=\"e-con-inner\">\n\t\t\t\t<div class=\"elementor-element elementor-element-046004e elementor-widget elementor-widget-text-editor\" data-id=\"046004e\" data-element_type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t\t\t\t\t\t<p><strong>17-Jan-2022<\/strong><br \/><a href=\"#\">Paladin Labs Inc. Announces the Launch of Xydalba\u00ae (dalbavancin for injection) in Canada<\/a><\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t<div class=\"elementor-element elementor-element-6c97292 e-flex e-con-boxed e-con e-parent\" data-id=\"6c97292\" data-element_type=\"container\">\n\t\t\t\t\t<div class=\"e-con-inner\">\n\t\t\t\t<div class=\"elementor-element elementor-element-390cd35 elementor-widget elementor-widget-text-editor\" data-id=\"390cd35\" data-element_type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t\t\t\t\t\t<p><strong>09-Jun-2021<\/strong><br \/><a href=\"https:\/\/www.paladin-pharma.com\/wp-content\/uploads\/2021\/06\/Wakix_EN.pdf\" target=\"_blank\" rel=\"noopener\">Paladin Labs Inc. Announces Approval of Wakix\u00ae (pitolisant) in Canada<\/a><\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t<div class=\"elementor-element elementor-element-0fc2fda e-flex e-con-boxed e-con e-parent\" data-id=\"0fc2fda\" data-element_type=\"container\">\n\t\t\t\t\t<div class=\"e-con-inner\">\n\t\t\t\t<div class=\"elementor-element elementor-element-0c83abc elementor-widget elementor-widget-text-editor\" data-id=\"0c83abc\" data-element_type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t\t\t\t\t\t<p><strong>12-Apr-2021<\/strong><br \/><a href=\"https:\/\/www.paladin-pharma.com\/wp-content\/uploads\/2021\/05\/Xydalba_EN.pdf\" target=\"_blank\" rel=\"noopener\">ADVANZ PHARMA and Endo Announce Partnership for Paladin Labs to Commercialize Xydalba\u00ae (dalbavancin hydrochloride) in Canada<\/a><\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t<div class=\"elementor-element elementor-element-451795c e-flex e-con-boxed e-con e-parent\" data-id=\"451795c\" data-element_type=\"container\">\n\t\t\t\t\t<div class=\"e-con-inner\">\n\t\t\t\t<div class=\"elementor-element elementor-element-5a198f6 elementor-widget elementor-widget-text-editor\" data-id=\"5a198f6\" data-element_type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t\t\t\t\t\t<p><strong>05-Jan-2021<\/strong><br \/><a href=\"https:\/\/www.prnewswire.com\/news-releases\/endo-announces-licensing-agreement-for-paladin-labs-inc-to-commercialize-abaloparatide-in-canada-301201070.html\" target=\"_blank\" rel=\"noopener\">Endo Announces Licensing Agreement for Paladin Labs Inc. to Commercialize Abaloparatide in Canada<\/a><\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t<div class=\"elementor-element elementor-element-22b6b96 e-flex e-con-boxed e-con e-parent\" data-id=\"22b6b96\" data-element_type=\"container\">\n\t\t\t\t\t<div class=\"e-con-inner\">\n\t\t\t\t<div class=\"elementor-element elementor-element-d97f026 elementor-widget elementor-widget-text-editor\" data-id=\"d97f026\" data-element_type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t\t\t\t\t\t<p><strong>22-Oct-2020<\/strong><br \/><a href=\"https:\/\/www.newswire.ca\/news-releases\/envarsus-r-pa-once-daily-immunosuppressive-therapy-for-kidney-and-liver-transplant-patients-is-now-reimbursed-in-ontario-quebec-manitoba-and-saskatchewan-843322955.html\" target=\"_blank\" rel=\"noopener\">Envarsus\u00ae PA Once-daily Immunosuppressive Therapy for Kidney and Liver Transplant Patients is Now Reimbursed in Ontario, Quebec, Manitoba and Saskatchewan<\/a><\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t<div class=\"elementor-element elementor-element-2c01c4f e-flex e-con-boxed e-con e-parent\" data-id=\"2c01c4f\" data-element_type=\"container\">\n\t\t\t\t\t<div class=\"e-con-inner\">\n\t\t\t\t<div class=\"elementor-element elementor-element-55c6f7e elementor-widget elementor-widget-text-editor\" data-id=\"55c6f7e\" data-element_type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t\t\t\t\t\t<p><strong>23-Oct-2019<\/strong><br \/><a href=\"https:\/\/www.newswire.ca\/news-releases\/movapo-r-apomorphine-hydrochloride-for-patients-with-advanced-parkinson-s-disease-now-reimbursed-in-most-canadian-provinces-864457282.html\" target=\"_blank\" rel=\"noopener\">Movapo\u00ae (apomorphine hydrochloride) for Patients with Advanced Parkinson&#8217;s Disease Now Reimbursed in Most Canadian Provinces<\/a><\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t<div class=\"elementor-element elementor-element-4abd43c e-flex e-con-boxed e-con e-parent\" data-id=\"4abd43c\" data-element_type=\"container\">\n\t\t\t\t\t<div class=\"e-con-inner\">\n\t\t\t\t<div class=\"elementor-element elementor-element-3604053 elementor-widget elementor-widget-text-editor\" data-id=\"3604053\" data-element_type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t\t\t\t\t\t<p><strong>31-Jul-2019<\/strong><br \/><a href=\"https:\/\/www.prnewswire.com\/news-releases\/helsinn-and-endo-announce-agreement-for-paladin-labs-inc-to-commercialize-pracinostat-in-canada-300893707.html\" target=\"_blank\" rel=\"noopener\">Helsinn and Endo Announce Agreement for Paladin Labs Inc. to Commercialize Pracinostat in Canada<\/a><\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t<div class=\"elementor-element elementor-element-503f65b e-flex e-con-boxed e-con e-parent\" data-id=\"503f65b\" data-element_type=\"container\">\n\t\t\t\t\t<div class=\"e-con-inner\">\n\t\t\t\t<div class=\"elementor-element elementor-element-b90c56a elementor-widget elementor-widget-text-editor\" data-id=\"b90c56a\" data-element_type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t\t\t\t\t\t<p><strong>22-Feb-2019<\/strong><br \/><a href=\"https:\/\/www.paladin-pharma.com\/wp-content\/uploads\/2019\/02\/Paladin_%20Envarsus%20PA%20PR_English%20FINAL%202-21-19.pdf\" target=\"_blank\" rel=\"noopener\">Paladin Labs Inc. Announces Approval of Envarsus PATM (tacrolimus prolonged-release tablets) in Canada<\/a><\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t<div class=\"elementor-element elementor-element-5f2113a e-flex e-con-boxed e-con e-parent\" data-id=\"5f2113a\" data-element_type=\"container\">\n\t\t\t\t\t<div class=\"e-con-inner\">\n\t\t\t\t<div class=\"elementor-element elementor-element-eabe1d0 elementor-widget elementor-widget-text-editor\" data-id=\"eabe1d0\" data-element_type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t\t\t\t\t\t<p><strong>25-Jul-2018<\/strong><br \/><a href=\"https:\/\/www.prnewswire.com\/news-releases\/bioprojet-and-endo-jointly-announce-agreement-for-paladin-labs-inc-to-commercialize-pitolisant-in-canada-300685977.html\" target=\"_blank\" rel=\"noopener\">Bioprojet and Endo Jointly Announce Agreement for Paladin Labs Inc. to Commercialize Pitolisant in Canada<\/a><\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t<div class=\"elementor-element elementor-element-39da5f0 e-flex e-con-boxed e-con e-parent\" data-id=\"39da5f0\" data-element_type=\"container\">\n\t\t\t\t\t<div class=\"e-con-inner\">\n\t\t\t\t<div class=\"elementor-element elementor-element-f863532 elementor-widget elementor-widget-text-editor\" data-id=\"f863532\" data-element_type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t\t\t\t\t\t<p><strong>23-Apr-2018<\/strong><br \/><a href=\"https:\/\/investor.endo.com\/2018-04-23-Paladin-Labs-Inc-Announces-Launch-of-New-Indication-for-XIAFLEX-R-Collagenase-Clostridium-Histolyticum-,-Broadening-Its-Use-to-the-Treatment-of-Appropriate-Patients-with-Peyronies-Disease\" target=\"_blank\" rel=\"noopener\">Paladin Labs Inc. Announces Launch of New Indication for XIAFLEX\u00ae (Collagenase Clostridium Histolyticum), Broadening Its Use to the Treatment of Appropriate Patients with Peyronie&#8217;s Disease<\/a><\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t<div class=\"elementor-element elementor-element-5fb232e e-flex e-con-boxed e-con e-parent\" data-id=\"5fb232e\" data-element_type=\"container\">\n\t\t\t\t\t<div class=\"e-con-inner\">\n\t\t\t\t<div class=\"elementor-element elementor-element-d351be1 elementor-widget elementor-widget-text-editor\" data-id=\"d351be1\" data-element_type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t\t\t\t\t\t<p><strong>19-Apr-2018<\/strong><br \/><a href=\"#\" target=\"_blank\" rel=\"noopener\">Paladin Labs Inc. Announces the Launch of Unisom\u00ae Snore Relief, the Only Natural Health Product Throat Spray Available in Canada to Help Relieve Symptoms Associated with Snoring<\/a><\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t<div class=\"elementor-element elementor-element-a018b85 e-flex e-con-boxed e-con e-parent\" data-id=\"a018b85\" data-element_type=\"container\">\n\t\t\t\t\t<div class=\"e-con-inner\">\n\t\t\t\t<div class=\"elementor-element elementor-element-53f9735 elementor-widget elementor-widget-text-editor\" data-id=\"53f9735\" data-element_type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t\t\t\t\t\t<p><strong>10-Jun-2015<\/strong><br \/><a href=\"https:\/\/www.businesswire.com\/newsroom#.VXsxOk3bK70\" target=\"_blank\" rel=\"noopener\">ARIAD and Paladin Announce Commercial Distribution Agreement for Iclusig (Ponatinib) in Canada<\/a><\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t<div class=\"elementor-element elementor-element-fef257b e-flex e-con-boxed e-con e-parent\" data-id=\"fef257b\" data-element_type=\"container\">\n\t\t\t\t\t<div class=\"e-con-inner\">\n\t\t\t\t<div class=\"elementor-element elementor-element-1a3c9b2 elementor-widget elementor-widget-text-editor\" data-id=\"1a3c9b2\" data-element_type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t\t\t\t\t\t<p><strong>9- Feb- 2015<\/strong><br \/><a href=\"#\" target=\"_blank\" rel=\"noopener\">Paladin Labs Announces the Canadian Launch of Zincofax\u00ae Spray<\/a><\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t<div class=\"elementor-element elementor-element-f38ea7c e-flex e-con-boxed e-con e-parent\" data-id=\"f38ea7c\" data-element_type=\"container\">\n\t\t\t\t\t<div class=\"e-con-inner\">\n\t\t\t\t<div class=\"elementor-element elementor-element-6212c53 elementor-widget elementor-widget-text-editor\" data-id=\"6212c53\" data-element_type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t\t\t\t\t\t<p><strong>19-Aug-2013<\/strong><br \/><a href=\"#\" target=\"_blank\" rel=\"noopener\">Paladin Labs Announces the Canadian Launch of Emtrix\u00ae<\/a><\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t<div class=\"elementor-element elementor-element-be2c7b5 e-flex e-con-boxed e-con e-parent\" data-id=\"be2c7b5\" data-element_type=\"container\" data-settings=\"{&quot;background_background&quot;:&quot;classic&quot;}\">\n\t\t\t\t\t<div class=\"e-con-inner\">\n\t\t\t\t<div class=\"elementor-element elementor-element-5fe5c7c elementor-widget elementor-widget-image\" data-id=\"5fe5c7c\" data-element_type=\"widget\" data-widget_type=\"image.default\">\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<img decoding=\"async\" src=\"https:\/\/paladin-pharma.com\/wp-content\/uploads\/elementor\/thumbs\/paladin_logo_white-rbnpdr63a6hd7rnsxc58h6ae96og4trn4ef0cpcc66.png\" title=\"paladin_logo_white\" alt=\"paladin_logo_white\" loading=\"lazy\" \/>\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t<div class=\"elementor-element elementor-element-703e2db elementor-hidden-desktop elementor-hidden-tablet elementor-hidden-mobile e-flex e-con-boxed e-con e-parent\" data-id=\"703e2db\" data-element_type=\"container\" data-settings=\"{&quot;background_background&quot;:&quot;classic&quot;,&quot;position&quot;:&quot;fixed&quot;}\">\n\t\t\t\t\t<div class=\"e-con-inner\">\n\t\t\t\t<div class=\"elementor-element elementor-element-2d9804d elementor-widget elementor-widget-text-editor\" data-id=\"2d9804d\" data-element_type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t\t\t\t\t\t<p>Paladin Pharma is part of Endo, Inc. \u2014 a highly focused generics and specialty branded pharmaceutical company. |\u00a0 <a href=\"https:\/\/endo.com\" target=\"_blank\" rel=\"noopener\">Learn More<\/a><\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t","protected":false},"excerpt":{"rendered":"<p>A leader in specialty pharmaceutical innovation. Welcome to Paladin Pharma Inc. Knight Therapeutics Announces Closing of Previously Announced Acquisition of Paladin06\/17\/2025MONTREAL, June 17, 2025 (GLOBE NEWSWIRE) &#8212; Knight Therapeutics Inc. (TSX: GUD) (&#8220;Knight&#8221;), a pan-American (ex-US) specialty pharmaceutical company, announced today that it has completed the acquisition of the Paladin business, under the terms of [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"elementor_theme","meta":{"footnotes":""},"class_list":["post-21","page","type-page","status-publish","hentry"],"_links":{"self":[{"href":"https:\/\/paladin-pharma.com\/index.php\/wp-json\/wp\/v2\/pages\/21","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/paladin-pharma.com\/index.php\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/paladin-pharma.com\/index.php\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/paladin-pharma.com\/index.php\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/paladin-pharma.com\/index.php\/wp-json\/wp\/v2\/comments?post=21"}],"version-history":[{"count":161,"href":"https:\/\/paladin-pharma.com\/index.php\/wp-json\/wp\/v2\/pages\/21\/revisions"}],"predecessor-version":[{"id":1304,"href":"https:\/\/paladin-pharma.com\/index.php\/wp-json\/wp\/v2\/pages\/21\/revisions\/1304"}],"wp:attachment":[{"href":"https:\/\/paladin-pharma.com\/index.php\/wp-json\/wp\/v2\/media?parent=21"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}